Physician profile

Robert Miller

Neurological Surgery · Lawrence, MA

NPI 1124250907

$4,426.94

in general payments reported to CMS, 2019-2025

8 companies · $4.00 in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Consulting Fee$1,350.03
Food and Beverage$101.87
Travel and Lodging$78.57

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Depuy Synthes Products, INC. $2,328.60 2022-2023
Spine Wave, INC. $1,198.33 2019
Globus Medical, INC. $587.25 2021-2023 Transcontinental / Transc Tps
Depuy Synthes Sales INC. $172.45 2019-2023 Vbb, X-Pac
Brainlab, INC. $67.14 2023 Image Guided Surgical Device
Abbvie INC. $33.60 2022
Orthofix Medical, INC. $23.25 2020-2025 Spinal-Stim
Avanir Pharmaceuticals, INC. $16.32 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Robert Miller

$4,426.94

in general payments reported 2019-2025

Years
2019-2025
Top company
Depuy Synthes Products, INC.

https://glasscript.com/doctor/1386978/robert-miller

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.